GEODE CAPITAL MANAGEMENT, LLC
Position in ANEB — Anebulo Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ANEB
as of Dec 31, 2025
· filed Feb 9, 2026
Position Value
$162,367
-$272,902 QoQ
Shares Held
160,760
-7.7% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 19 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANEB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ANEB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $162,367 | 160,760 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $435,269 | 174,108 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $296,236 | 205,720 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $267,043 | 205,418 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $153,452 | 91,341 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $169,434 | 87,790 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $140,070 | 51,308 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $65,369 | 22,777 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||